QNTM Labs
Private Company
Funding information not available
Overview
QNTM Labs, founded in 2020 and based in Odense, Denmark, is a specialized contract research organization (CRO) focused on analytical chemistry and QC testing services for the pharmaceutical sector. The company operates a state-of-the-art, GMP-certified facility offering a comprehensive suite of services including method development, validation, QC release testing, natural product analysis (e.g., cannabis), and stability studies. By providing these critical, compliance-driven services, QNTM Labs enables pharmaceutical and biotech companies to outsource complex QC workflows, reduce capital expenditure, and accelerate product development cycles. Its client-centric model and pharmacopeial expertise position it as a trusted partner for ensuring drug quality and regulatory readiness.
Technology Platform
GMP-certified analytical laboratory infrastructure and expertise in pharmacopeial compliance, method development/validation, and specialized testing (e.g., ICP-MS, cannabis monograph analysis).
Opportunities
Risk Factors
Competitive Landscape
QNTM Labs competes in the analytical testing and QC CRO segment against large multinational players like Eurofins, Labcorp, and SGS, as well as numerous regional and niche laboratories. Its differentiation is based on a specialized focus on pharmacopeial standards, a client-centric tailored approach, and specific expertise in emerging areas like cannabis testing within the European regulatory framework.